Elevance Health Q3 Adjusted EPS $8.99 Beats $8.45 Estimate, Sales $42.85B Beat $42.53B Estimate
Portfolio Pulse from Benzinga Newsdesk
Elevance Health (NYSE:ELV) reported Q3 earnings of $8.99 per share, beating the analyst consensus estimate of $8.45 by 6.39%. This is a 20.51% increase from the same period last year. The company also reported quarterly sales of $42.85 billion, beating the analyst consensus estimate of $42.53 billion by 0.75%. This is a 7.29% increase from the same period last year.
October 18, 2023 | 10:02 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Elevance Health's Q3 earnings and sales exceeded analyst estimates, indicating a strong financial performance. This could potentially lead to a positive impact on the company's stock price.
Elevance Health's Q3 earnings and sales have surpassed analyst estimates, which is typically a positive signal to investors and can lead to an increase in the stock price. The company's earnings have increased by 20.51% and sales by 7.29% compared to the same period last year, indicating a strong financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100